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SUMMARY
Epithelial tubes are essential components of metazoan organ systems that control the flow of fluids and the
exchange of materials between body compartments and the outside environment. The size and shape of the
central lumen confer important characteristics to tubular organs and need to be carefully controlled. Here, we
identify the small coiled-coil protein BBLN-1 as a regulator of lumen morphology in the C. elegans intestine.
Loss of BBLN-1 causes the formation of bubble-shaped invaginations of the apical membrane into the cyto-
plasm of intestinal cells and abnormal aggregation of the subapical intermediate filament (IF) network.
BBLN-1 interacts with IF proteins and localizes to the IF network in an IF-dependentmanner. The appearance
of invaginations is a result of the abnormal IF aggregation, indicating a direct role for the IF network in main-
taining lumen homeostasis. Finally, we identify bublin (BBLN) as the mammalian ortholog of BBLN-1. When
expressed in the C. elegans intestine, BBLN recapitulates the localization pattern of BBLN-1 and can
compensate for the loss of BBLN-1 in early larvae. Inmouse intestinal organoids, BBLN localizes subapically,
together with the IF protein keratin 8. Our results therefore may have implications for understanding the role
of IFs in regulating epithelial tube morphology in mammals.
INTRODUCTION
Epithelial and endothelial tubes are fundamental building units of
many organs, including the digestive tract, vascular system, and
lung. Tubular organs are essential for molecular transport and
form protective barriers to the outside environment.1–5 The Cae-
norhabditis elegans intestine provides a simple model to study
the regulation of lumen morphology. It is composed of 20 cells
arranged in nine segments surrounding a central lumen (Fig-
ure 1A).6,7 Specialized cell-cell junctions connect neighboring
cells and ensure impermeability of the lumen.8 The intestinal
cells are polarized along an apicobasal axis and resemble
mammalian enterocytes at the ultrastructural level.9 The
lumen-forming apical surface of both cell types is covered by
microvilli that contain bundled actin filaments and are supported
by the subapical actin-rich terminal web.7,10 The luminal surface
is further supported by an intermediate-filament (IF) rich fibrous
sheet that directly underlies—and is likely connected to—the ter-
minal web.
The C. elegans IF network forms a particularly electron-
dense structure anchored at the lateral cell junctions that is
known as the ‘‘endotube.’’9–11 Cytoplasmic IF proteins form
resilient flexible networks that mediate mechanical properties
of cells and tissues.12,13 In tubular epithelia, subapical IF net-
works are ideally positioned to contribute to the regulation of
lumen morphology and functioning.13–17 In the C. elegans intes-
tine, loss of IF subunits or of the IF organizers IFO-1 and SMA-5
can result in morphological abnormalities of the lumen and
increased susceptibility to microbial, osmotic, and oxidative
stresses.18–21
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Figure 1. The intestines of mib41 and mib42 mutants show cytoplasmic invaginations
(A) Schematics of the C. elegans intestine and localization of proteins relevant for this study.
(B–D) Intestinal apical membranemorphology in L4 animals visualized by ERM-1::GFP. Dashed lines indicate position of cross-section. Schematics depict cross-
section with apical membrane in red. Unless otherwise indicated, in this and all other figures, images were acquired using spinning-disk confocal microscopy,
lateral views are maximum intensity projections, and anterior is to the left. All scale bars indicate 10 mm.
(E and F) Genomic structure of C15C7.5 (E) and representation of the C15C7.5 protein with predicted domains (F).
(G) Progression of mib42 and bbln-1(null) phenotypes visualized by ERM-1::GFP and ERM-1::mCherry, respectively.
(H) Quantification of invagination number in bbln-1(null) animals. Each point represents the average number of invaginations per intestinal ring in one animal. Data
show median ± interquartile range. Differences are not significant (Kruskal-Wallis followed by Dunn’s multiple comparisons test; p > 0.99).
(I) Correlation between cell and invagination width in bbln-1(null) animals, color coded per larval stage. Linear regression is shown for all data points combined.
Data are analyzed with nonparametric Spearman correlation.
See also Figures S1 and S2 and Video S1.
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Here, we report the identification of an evolutionary conserved
regulator of intestinal tube morphology and IF organization we
term bbln-1, for bulges budding from the intestinal lumen.
bbln-1 mutant intestines develop large invaginations of the api-
cal lumen into the cytoplasm of intestinal cells. We show that
these cytoplasmic invaginations are likely the result of an aggre-
gated IF network state caused by loss of bbln-1. We also identi-
fied a mammalian ortholog of BBLN-1, which we termed bublin
(BBLN). BBLN shares multiple candidate protein interaction
partners with BBLN-1 and can partially substitute for BBLN-1
functioning in the C. elegans intestine. Our findings provide
further evidence that the subapical IF network plays an active
role in regulating the morphology of tubular epithelia, although
the structural and functional conservation from C. elegans to hu-
mans provides a model for studying IF modulation in vivo.
RESULTS
Loss of bbln-1 causes cytoplasmic invaginations of the
intestinal apical membrane
In a genetic screen for lumen morphology defects, we identified
two viable mutants (mib41 and mib42) with dramatic bubble-
shaped protrusions of the apical plasma membrane into the
cytoplasm of C. elegans intestinal cells (Figures 1A–1D).
Complementation analysis indicated that mib41 and mib42
affect different loci. Through single-nucleotide polymorphism
mapping and whole-genome sequencing,22,23 we identified a
single cluster of candidate mutations for each allele.
Formib41, only one candidatemutationwas predicted to exert
a detrimental effect on protein function: an arginine to tryptophan
substitution in the kinase domain of SMA-5 (Arg124Trp in SMA-
5a; Figure S1A). sma-5 mutations induce a lumen invagination
phenotype similar to mib41 mutants,21 and the sma-5(n678)
allele24 failed to complement mib41. Thus, mib41 is a novel
sma-5 allele.
The mib42 sequencing data also yielded a single potentially
deleterious mutation within a predicted open reading frame
(ORF): an early stop at the fifth codon of the uncharacterized
gene C15C7.5 (Figures 1E and 1F). C15C7.5 RNA interference
(RNAi) phenocopiedmib42 (Figure S1B), and transgenic expres-
sion ofGFP::C15C7.5 from the intestine-specific vha-6 promoter
rescued the invagination phenotype of mib42 (Figure S1C). We
used CRISPR-Cas9 to generate the mib70-null allele that re-
moves the C15C7.5 coding sequence, from here on referred to
as C15C7.5(null). The C15C7.5(null) allele caused cytoplasmic
invaginations (Figure S1D) and did not complement mib42.
Together, these data show that mib42 is an allele of C15C7.5.
The invagination phenotype in C15C7.5(null) animals was more
severe than in mib42 mutants (Figure 1G), indicating that
mib42 is a partial loss-of-function mutation. We named the
C15C7.5 gene bbln-1 for bulges budding from the intestinal
lumen.
bbln-1(null) animals are homozygous viable but somewhat
developmentally delayed (Figures S1E and S1F). This delay is
likely a consequence of the intestinal abnormalities, as intestinal
expression of GFP::BBLN-1 nearly fully rescued the develop-
mental delay (Figures S1E and S1F). In bbln-1(null) animals, in-
vaginations were visible from hatching, and the number of invag-
inations remained constant throughout development (Figures 1G
and 1H). Time-lapse imaging showed that the invaginations were
stable over a period of several hours (Video S1). Invagination
width correlated with intestinal cell width, and in late larval and
adult stages, invaginations had an elongated appearance (Fig-
ure 1I). The bbln-1 invaginations were spread uniformly along
the length of the intestine (Figures 1D and 1G). However, in
cross-section, invaginations seemed to preferentially localize
at the vertices of the ellipse-shaped lumen, in proximity to cell
junctions. This was particularly noticeable in mib42 animals,
which have fewer invaginations than bbln-1(null) mutants (Fig-
ure 1D). Visualizing invaginations in a bbln-1(mib42) strain ex-
pressing the junctional marker DLG-1::mCherry confirmed that
invaginations occurred in proximity to cell junctions (Figures
S2A–S2D).
To assess intestine morphology and integrity, we fed animals
with three sizes of Texas Red-dextran conjugates (3 kDa,
10 kDa, and40 kDa). Inwild-type animals, TexasRedsignals filled
the lumen (Figures S2E–S2G). In bbln-1(mib42) animals, all invag-
inations contained Texas Red signal, indicating that they are
contiguouswith the lumen.Wenever observed internalized invag-
inations or presenceof TexasRedsignal in thecytoplasmof intes-
tinal cells, indicating that the invaginationsarenot internalized.We
also did not observe paracellular passage of conjugates in the in-
testine (Figures S2F and S2G). This contrasted with the pharynx,
where we observed paracellular passage of the 3-kDa conjugate
in bothwild-type andbbln-1 animals (FiguresS2HandS2I). These
data indicate that paracellular permeability of the intestine is not
significantly affected by loss of BBLN-1.
BBLN-1 is a small coiled-coil protein that localizes
dynamically to IF-rich structures
bbln-1 is predicted to encode a single protein isoform of just 125
amino acids (aas) with a central coiled-coil domain ( aas 39–102)
flanked by intrinsically disordered regions (Figure 1F). To inves-
tigate the localization pattern of BBLN-1, we engineered an
endogenous BBLN-1::GFP fusion. Homozygous gfp::bbln-1 an-
imals show no intestinal lumen defects or developmental delay
(Figures S1E and S1F), demonstrating that GFP::BBLN-1 is func-
tional. In contrast, a C-terminally tagged BBLN-1::mKate2
variant proved non-functional.
BBLN-1 was first apparent at the comma stage of embryonic
development, at the apical domain of intestinal cells (Figure 2A).
In subsequent embryonic stages, BBLN-1 became visible in the
hypodermis and pharynx as well. In larval and adult stages, we
detected BBLN-1 in many epithelial tissues, including the phar-
ynx, intestine, excretory canal, and hypodermis (Figure 2B). In
each of these tissues, the distribution of BBLN-1 was similar to
previously reported distributions of IF proteins.8,25–28 To investi-
gate the localization of BBLN-1 relative to IFs, we engineered an
endogenous IFB-1::mCherry fusion. Close overlap between
GFP::BBLN-1 and IFB-1::mCherry in each tissue indicates that
BBLN-1 indeed localizes to IFs (Figures S3A–S3C).
In the intestine, BBLN-1 localized subapically and at cell junc-
tions (Figure 2Biv), suggesting localization to the endotube.10We
therefore generated an endogenous IFB-2::mCherry fusion and
analyzed the localization of BBLN-1 relative to IFB-2 and
ERM-1,which localizes tomicrovilli.29,30Consistentwith localiza-
tion to the endotube, we found that BBLN-1 co-localized with
IFB-2, basal toERM-1 (Figures 2Cand2D). Todeterminewhether
ll
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BBLN-1 stably associates with the IF network, we performed
fluorescence recovery after photobleaching (FRAP) experiments.
IFB-2 recovered only15% in 150 s (Figures 2E and 2F). Similar
slow recovery was reported for IFA-1 and IFB-1 in the pharynx.27
In contrast, BBLN-1 recovered 90% within the same period.
Together, these results indicate that BBLN-1 is a dynamic
component of the endotube in intestinal cells.
The subcellular localization of BBLN-1 depends on IFs
We next determined whether the apical localization of BBLN-1
depends on IFs. We used RNAi feeding to knock down each of
the six intestinal IF proteins that are part of the endo-
tube.10,19,31,32 We observed significant reduction in apical
BBLN-1 upon knockdown of IFB-2, IFD-1, IFD-2, or IFP-1 (Fig-






Figure 2. BBLN-1 localizes dynamically to IF-rich structures
(A and B) Distribution of GFP::BBLN-1 during late embryonic development (A) and in different tissues in late L3–young adult animals (B). Arrowhead indicates
apical junction. All scale bars indicate 10 mm.
(C and D) Distribution of GFP::BBLN-1 compared with ERM-1::mCherry (C) and IFB-2::mCherry (D) at the apical domain of intestinal cells of L3 larvae. Dashed
lines indicate sites of intensity profiles.
(E and F) Stills from time-lapse imaging (E) and FRAP curves (F). Time-lapse data were acquired at 1-s intervals for GFP::BBLN-1 and 5-s intervals for IFB-
2::mCherry. Thin lines and shading represent the mean ± SD. No plateau or half-times could be accurately determined for IFB-2::mCherry; bbln-1(null).
See also Figure S3.
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was most striking. IFB-2 is an essential component of the apical
intestinal IF network, and loss of IFB-2 results in a complete
absence of the endotube.19,20 Therefore, the strong reduction
in apical BBLN-1 likely reflects the loss of all IFs from the apical
domain. We also examined BBLN-1 in the excretory canal of
ifc-2(RNAi) animals, as IFC-2 has been shown to be important
for the structure of this tissue.25 We observed relocalization of
BBLN-1 from the apical cortex to the cytoplasm and basal mem-
brane, which suggests that dependency on IFs is a general
aspect of BBLN-1 localization (Figure 3C).
The reliance of BBLN-1 localization on an intact IF network
indicates a potential association with IF proteins. To identify
candidate interacting proteins, we performed affinity purifica-
tion of GFP::BBLN-1 frommixed-stage C. elegans cultures, fol-
lowed by mass spectrometry analysis. Consistent with the
localization and dependency on IFs, the highest ranking pro-
teins identified included all intestinal IF proteins except IFP-1
(Figure 3D).
To further confirm the dependency of BBLN-1 on IFs, we exam-
ined the effects of inactivation of known regulators of IF organiza-
tion on BBLN-1. In addition to sma-5, loss of ifo-1, act-5, and




Figure 3. BBLN-1 requires IFs for its apical
localization in the intestine
(A) Intestinal GFP::BBLN-1 distribution and apical
membrane morphology, visualized by ERM-1::
mCherry, upon RNAi knockdown of targets indi-
cated to the left. EV, empty vector. All scale bars
indicate 10 mm.
(B) Quantification of GFP::BBLN-1 levels at the
intestinal apical domain of larvae subjected to
RNAi. Each data point represents the average of
six or eight measurements in a single animal. Data
are presented as mean ± SEM and analyzed
with ordinary one-way ANOVA followed by Dun-
nett’s multiple comparisons test; ns, p > 0.05;
**p < 0.005; ****p < 0.0001.
(C) GFP::BBLN-1 distribution in the excretory ca-
nal upon RNAi knockdown of ifc-2 or EV control.
(D) Mass spectrometry hits for GFP::BBLN-1 pull-
down plotted as correlation between fold-change
(FC) score A and more stringent FC score B. Data
points are color coded for different SAINT proba-
bility scores.
See also Figure S6.
C. elegans intestine.10,18,33,34 We depleted
each protein by RNAi in strains expressing
ERM-1::mCherry or IFB-2::mCherry,
together with GFP::BBLN-1. In each case,
the localization of BBLN-1 mimicked the
localization pattern of IFB-2, including ba-
solateral mislocalization in let-413(RNAi)
embryos (Figures 4A–4C). This confirms
that BBLN-1 associates with IFs.
In sma-5(RNAi) intestines, we observed
a significant reduction of cortical BBLN-1
levels (Figure 4D). This suggests that
sma-5 acts upstream of bbln-1. However,
inactivation of sma-5 by RNAi in a bbln-
1(null) background resulted in more severe intestinal abnormal-
ities than either sma-5(RNAi) or bbln-1(null) alone (Figure 4E).
Thus, although sma-5 may act in part through bbln-1, these
genes also have independent functions.
Collectively, the dependence on IFs, the co-localization of
BBLN-1 with aberrantly localized IFB-2, and the co-purification
of BBLN-1 with IF proteins suggest that BBLN-1 associates
with the IF network.
Loss of bbln-1 compromises the integrity of the IF
network
To investigate whether apical domain invaginations in bbln-1
mutants were associated with defects in intestinal IF organiza-
tion, we analyzed the distribution of IFB-2, IFC-2, and IFD-2 in
bbln-1(null) animals. In control animals, IFB-2 and IFC-2 were
distributed evenly along the adluminal domain and were en-
riched at cell junctions (Figures 5A and 5C). These localization
patterns match prior observations.18,19,21,35 In contrast, IFD-2
showed a punctate localization pattern and was excluded from
cell junctions (Figures 5E and S5A), indicating functional special-
ization within the IF network. Upon loss of bbln-1, all three IF pro-
teins retained their subapical localization but formed a network
ll
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of cables or bundles surrounding protrusions into the cytoplasm
(Figures 5B, 5D, and 5F). To investigate the stability of IFs within
the aggregated bundles, we performed FRAP on IFB-2::mCherry
in bbln-1(null) animals. IFB-2 showed very little fluorescence re-
covery, appearing, if anything, even more stable than in control
animals (Figures 2E and 2F). Together, these data indicate that
BBLN-1 is required for the integrity of the IF network, but not
for IF recruitment to the subapical cortex.
Loss of BBLN-1 did not cause defects in the organization of
the IF network in the pharynx or hypodermis (Figures S4A–
S4C). The only minor effect we noticed was in the excretory ca-
nal, where IFB-1::mCherry puncta of unknown nature were ab-
sent in bbln-1 mutants (Figure S4D). The lack of severe defects
in other tissues indicates that the intestinal IF network is uniquely
sensitive to BBLN-1 loss.
To investigate whether BBLN-1 is required for IF network
integrity throughout development, we used the auxin-inducible
degradation (AID) system.36,37 We tagged BBLN-1 with GFP
and the AID-degron and expressed TIR1 from the intestine-spe-





Figure 4. BBLN-1 co-localizes with mislocalized IFs
(A) Intestinal GFP::BBLN-1 distribution and apical membrane morphology, visualized by ERM-1::mCherry, after RNAi knockdown of targets indicated on the left.
Same control is shown as in Figure 3A because data are from a single experiment. All scale bars indicate 10 mm.
(B and C) GFP::BBLN-1 and IFB-2::mCherry distribution in L2–L4 larvae (B) and 2-fold embryos (C) after RNAi knockdown of targets indicated on the left.
(D) Quantification of GFP::BBLN-1 levels at the intestinal apical domain of L3/L4 larvae subjected to RNAi knockdown of sma-5. Each data point represents the
average of six or eight measurements in a single animal. Data show mean ± SEM. Ordinary one-way ANOVA followed by Dunnett’s multiple comparisons test,
****p < 0.0001. EV control data are same as in Figure 3B.
(E) Apical membrane morphology, visualized by ERM-1::mCherry, after RNAi knockdown of targets indicated on the left in bbln-1(+) or bbln-1(null) background.
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animals, apical GFP::AID::BBLN-1 was no longer detectable
(Figure S5B). We next added auxin to late L1 stage or early L4
stage animals and imaged the intestinal lumen after 24 and
48 h (Figure S5C). Irrespective of the starting time point, approx-
imately half of the animals had developed invaginations after 24 h
of auxin treatment (Figure S5D; 48-h time point). The remainder
showed small ‘‘holes’’ in the IFB-2::mCherry fluorescent pattern
(Figure S5E). Eventually, all animals treated with auxin from L1
developed cytoplasmic invaginations (Figure S5D; 72-h time
point). These data show that bbln-1 is required to maintain the
integrity of the IF network throughout development.
We also investigated whether re-expression of BBLN-1 could
revert already formed invaginations. We hatched GFP::AID::
BBLN-1 animals in the presence of auxin and transferred L1 ani-
mals to plates lacking auxin. BBLN-1 levels recovered within
24 h (Figure S5F). However, we still observed invaginations in L4
and adult animals (Figures S5G and S5H). Presence of BBLN-1
is therefore not sufficient to restore an already malformed luminal
domain.
To investigate whether bbln-1 loss affects apical actin distri-
bution or cell polarity, we examined the localization of the in-
testinal actin ACT-5 and the polarity proteins LET-413/Scrib
and PAR-6. In bbln-1(null) animals, ACT-5 smoothly decorated
the surface of the cytoplasmic invaginations and was not
enriched in bundles or cables (Figures S5I and S5J). Inactiva-
tion of bbln-1 by RNAi also did not affect the basolateral
localization of LET-413 or the apical localization of PAR-6
(Figures S5K and S5L). Thus, loss of BBLN-1 does not disrupt
the terminal web or microvillar actin, and the effects of








Figure 5. Loss of bbln-1 compromises the
integrity of the IF network
Organization of the intestinal IF network visualized
with IFB-2::mCherry (A and B), IFC-2a/e::YFP
(C and D), or GFP::IFD-2 (E and F) in control (A, C,
and E) or bbln-1(null) (B, D, and F) animals. Large
panels are lateral views, and small panels are
cross-sections at the site indicated by the dashed
lines. All scale bars indicate 10 mm. See also Fig-
ures S4 and S5.
To confirm loss of IF network integrity
in bbln-1 mutants, we performed elec-
tron microscopy (EM). As previously re-
ported for sma-5 mutant intestines, the
endotube in bbln-1(null) animals was
lost or diminished at sites of invagina-
tion and thickened around the base of
invaginations (Figure 6, compare A
versus B or C versus D).21 Neverthe-
less, as in wild-type animals, aggre-
gated endotube material in bbln-1(null)
intestines still maintained a distance
from the apical membrane, consistent
with the continued presence of the sub-
apical terminal web (Figures 6A and 6B,
inlays). Finally, similar to ifb-2 mu-
tants,20 microvilli were still abundant in invaginations, showing
that bbln-1 and a fully assembled endotube are not required
for microvilli formation.
Taken together, the EM and light microscopy observations
demonstrate that the intestinal IF network collapses and aggre-
gates into stable bundles upon loss of BBLN-1, without affecting
other aspects of intestinal epithelial polarity or the actin
cytoskeleton.
Apical IF aggregation drives cytoplasmic invaginations
We next sought to better understand the relationship between
the cytoplasmic invaginations and collapsed IF network. If in-
vaginations are a consequence of the IF network collapse,
direct disruption of the IF network might similarly cause invagi-
nations. As recently reported,19 ifd-2(RNAi) induced cyto-
plasmic invaginations, though with much lower penetrance
and severity than bbln-1 mutants (Figure 3A). To determine
whether invaginations in ifd-2(RNAi) animals are due to the par-
tial loss of BBLN-1, we performed ifd-2(RNAi) in a bbln-1(null)
mutant background. The combined loss of ifd-2 and bbln-1 re-
sulted in more severe lumen abnormalities than loss of bbln-1
alone (Figure S6A), indicating that both genes have at least
partially independent functions. These data support the hypoth-
esis that cytoplasmic invaginations in bbln-1 mutants are
caused by defects in the IF network.
Surprisingly, despite the loss of the complete intestinal IF
network, ifb-2 knockout animals display only mild intestinal
lumen morphology defects.19 We similarly observed an irregular
lumenmorphology in only a subset of ifb-2(RNAi) animals and no
cytoplasmic invaginations (Figures 3A and S6B). If the bbln-1 in-
vaginations are due to an altered IF network state, loss of the IF
ll
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network should suppress the bbln-1 phenotype. Indeed, lumen
morphology in an ifb-2(kc14); bbln-1(null) double mutant ap-
peared identical to that seen upon loss of IFB-2 (Figures 3A
and S6C).19 We also did not observe cytoplasmic invaginations
in the double mutant by EM (Figure S6D). No endotube was
visible, confirming the requirement for IFB-2 in endotube forma-
tion. We did observe occasional small-membrane protrusions
directed toward the lumen (Figure S6E), which were also visible
by light microscopy in both ifb-2(kc14); bbln-1(null) (Figure S6F)
and ifb-2(RNAi) animals (Figure S6Biii). These are therefore likely
to be the result of IFB-2 depletion alone.
Together, our data are consistent with a model in which loss of
bbln-1 leads to an altered, pathogenic IF network state that re-
sults in cytoplasmic invaginations.
BBLN is the mammalian ortholog of BBLN-1
To investigate whether BBLN-1 is conserved in mammals, we
performed an iterative homology search using Jackhmmer.38
The uncharacterized protein C9orf16 was the only candidate
mammalian homolog (E-value 3.8e16). The 83-aa human
C9orf16 protein is predicted to consist of a coiled-coil
domain, flanked by intrinsically disordered regions—similar
to BBLN-1 (Figure 7A). A reciprocal Jackhmmer search
identified BBLN-1 as the only C. elegans homolog of
C9orf16 (E-value 8.4e07). Given the bi-directional best hit
and absence of other candidate orthologs, we consider it
likely that BBLN-1 and C9orf16 are evolutionary orthologs



























































Figure 6. Loss of bbln-1 compromises the integrity of the endotube
Ultrastructure of the apical domain (A and B) and apical junctions (C and D) in intestinal cells of bbln-1(+) and bbln-1(null) adult animals visualized by transmission
electron microscopy. Boxed region is shown enlarged, and arrowheads point to the endotube. Schematics indicate actin bundles in dark blue, endotube in red,
and junction in gray.
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To investigate whether BBLN and BBLN-1 are functionally
conserved, we expressed GFP::BBLN in the intestine of
C. elegans from an extrachromosomal array. BBLN showed api-
cal and perinuclear enrichment, as did GFP::BBLN-1 when
expressed from an extrachromosomal array (Figure 7B). More-
over, the subapical localization of BBLN was dependent on the
presence of an IF network (Figure S7A). To determine whether






Figure 7. Bublin is the mammalian homolog of BBLN-1
(A) Schematic of C. elegans BBLN-1 and human C9orf16 proteins.
(B) Overexpression of GFP-tagged BBLN-1 and bublin (BBLN [Hs]) in C. elegans L3-stage larvae driven by the intestine-specific vha-6 promoter. All scale bars
indicate 10 mm.
(C) Apical membrane morphology visualized by ERM-1::mCherry in a bbln-1(null) L1 larva with mosaic expression of GFP-tagged BBLN (Hs) from an extra-
chromosomal array. A cell without GFP::BBLN (Hs) expression (dotted outline) displays cytoplasmic invaginations (arrowheads).
(D) Quantification of invagination number in bbln-1(null) early L1 intestinal cells with or without GFP::BBLN (Hs) expression. Analysis was performed within 4 h of
hatching. Each dot corresponds to a single cell. Data show median ± interquartile range with Tukey whiskers. Mann-Whitney test, ****p < 0.0001.
(E) Western blots of Biotin pull-down from extracts of HEK293T cells transfected with BirA, mCherry::KRT8, KRT18, and either BioGFP::BBLN or BioGFP alone as
control. Blots were probed for KRT8 (top) and GFP (bottom). Input is 10% of the biotin pull-down.
(F) Point-scanning confocal microscopy images of HeLa cell stained for BBLN, pericentrin (PCNT), and tyrosinated a-tubulin.
(G) mCherry::BBLN-1 and GIP-2::GFP distribution in the early C. elegans embryo.
(H and I) Section of mouse small intestinal organoid immunostained for BBLN and KRT8 (top) or with phalloidin to visualize actin (bottom). Images were acquired
using point-scanning confocal microscopy. Graphs show fluorescent intensity from lumen to cytoplasm (dotted arrow indicates example). Fluorescent intensity
was measured across all cells that are in focus and displayed as mean ± SD.
See also Figure S7.
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GFP::BBLN in a bbln-1(null) background. bbln-1(null) animals all
show invaginations from hatching (Figure 7D). In contrast, cells
expressing GFP::BBLN did not show invaginations at hatching
(Figures 7C and 7D). As animals developed, invaginations
formed in all cells, and animals became phenotypically indistin-
guishable from non-transgenic animals by mid-L1 stage. Thus,
expression of BBLN delays the invagination phenotype in young
larvae. Together, these findings indicate that BBLN is a func-
tional homolog of BBLN-1.
We next investigated whether the association with IFs is
conserved. Keratin 8 (KRT8) is the most common type II keratin
IF in simple epithelia, and in enterocytes, KRT8 is part of an api-
cal IF network.39 As KRT8 forms functional heterodimers with
KRT18,40 we investigated whether BBLN interacts with KRT8/
18 by affinity purification. Pull-down analysis from HEK293T
cell lysates showed that KRT8/18 co-purify with BBLN (Fig-
ure 7E). Additionally, multiple high-throughput studies found
BBLN as an interactor of the type I intestinal KRT20.41–43 Thus,
the association with IFs is conserved between BBLN-1 and
BBLN.
We also performed mass spectrometry analysis on BBLN pu-
rified from HEK293T cells. The top scoring hit was V-ATPase
subunit D (ATP6V1D), the ortholog of C. elegans VHA-14 and
second highest scoring hit in our BBLN-1 interaction screen (Fig-
ures S7B and 4D). We additionally found subunit F of this com-
plex (ATP6V1F), the ortholog of the high-confidence BBLN-1
interactor VHA-9. Thus, BBLN-1 and BBLN share overlapping
candidate interaction partners.
Finally, we investigated the subcellular localization of BBLN
in mammalian cells using a GFP::BBLN expression construct
and a polyclonal antibody directed against human BBLN. In
HeLa cells expressing GFP::BBLN, immunostaining and GFP
fluorescence patterns overlapped, demonstrating that the anti-
body recognizes BBLN (Figure S7C). We next immunostained
HeLa cells for BBLN and KRT8. However, we did not detect
overlap between the BBLN and KRT8 localization patterns
(Figure S7D). Thus, whereas C. elegans BBLN-1 appears to
exclusively co-localize with IFs, this is not the case for
BBLN. Interestingly, in dividing HeLa cells, BBLN localized to
interpolar and kinetochore microtubules, a localization we
had not observed for BBLN-1 (Figure 7F). We re-examined
the localization of BBLN-1 in C. elegans embryonic mitotic
cells also expressing the centrosome marker GIP-2::GFP/
g-tubulin. BBLN-1 was enriched at the interpolar region (Fig-
ure 7G), indicating that both BBLN-1 and BBLN operate at
the mitotic spindle.
HeLa cells do not contain the subapical IF web present in
C. elegans intestinal cells and in differentiated enterocytes. We
therefore examined the localization of BBLN in mouse small in-
testinal organoids, which mimic the normal structure and
composition of the intestinal epithelium more closely. In organo-
ids, BBLN showed clear enrichment at the apical domain of in-
testinal epithelial cells. BBLN localized just below the apical actin
network, at the same level as KRT8 (Figures 7H and 7I). Thus, the
localization of BBLN inmouse intestinal organoidsmimics that of
BBLN-1 in C. elegans intestinal cells. Collectively, the overlap in
localization, rescue of phenotype, and similarity in putative inter-
action partners suggest that BBLN and BBLN-1 have at least
partially overlapping functionality.
DISCUSSION
Using an unbiased approach in the animal model C. elegans, we
identified the small protein BBLN-1 as a regulator of IFs and
tubular architecture of the intestinal epithelium. Loss of bbln-1
causes a disorganized IF network organization. Strikingly, loss
of the apical IF network through knockout of ifb-2 suppressed
the bbln-1 phenotype, demonstrating that the presence of apical
IFs is a prerequisite for invagination formation. The most likely
explanation is that bbln-1 causes an altered, pathogenic IF
network state that leads to the formation of invaginations into
the cytoplasm. When we were preparing this work for publica-
tion, it came to our attention that some similar observations
were made in a dissertation that describes the identification of
a mutant carrying the same point mutation present in bbln-
1(mib42).44
We also identified C9orf16 as the mammalian ortholog of
BBLN-1 and named it bublin coiled-coil protein (BBLN). Expres-
sion of BBLN was able to partially suppress the bbln-1 pheno-
type, indicating functional conservation. Although BBLN-1
seems to strictly co-localize with IFs in C. elegans, this is not
the case for BBLN. BBLN localized at the level of IFs in mouse
intestinal organoids, but we did not observe co-localization
with KRT8 in HeLa cells. Thus, although BBLN may regulate IF
organization, its functioning may have diverged between
C. elegans and mammals.
Why a compromised IF network leads to cytoplasmic invagi-
nations is not clear. One explanation is that pressure from the
lumen physically forces invaginations through weak spots in
the IF network. However, ifb-2 mutants that lack an apical IF
network entirely have a largely normal intestinal morphology
and do not show lumen widening until the L4 stage.19 Possibly,
the actin network compensates for the loss of the IF network
and delimits luminal widening. The presence of compensatory
mechanisms involving actin is supported by the observation
that loss of ifb-2 leads to an increase in apical levels of the
actin-bundling protein plastin 1 (PLST-1).19 Another explanation
for the formation of invaginations is that the IF network plays a
more-direct instructive role in determining the width of the lumen
or the surface area of the apical membrane. Such a role has
recently been proposed for the excretory canal, where IFs
work in conjunction with actin and tubulin to control intracellular
lumenogenesis.26 Here, IFs are hypothesized to regulate access
of membrane formation promoting vesicles to the lumen to
restrain lateral lumen expansion. Defects in apical membrane
trafficking in the intestine have been shown to cause ectopic
lateral lumen formation.45 Hence, it is possible that the IF
network plays a role in apical trafficking in the intestine.
The molecular nature of the change to the IF network in bbln-1
mutants also remains to be determined. The protein sequence of
BBLN-1 does not clearly hint at its function, but possible roles
include cross-linking or stabilizing IF filaments and anchoring
of IFs to components of the overlying terminal web. The ten-
dency of invaginations to occur at cell junctions may also indi-
cate a role in linking IFs to cell junctions. However, our FRAP
data indicate that BBLN-1 associates dynamically with the IF
layer. Hence, the activities of BBLN-1 may be more indirect,
for example, localizing unidentified regulators to the IF network
or promoting post-translational modifications of IFs. Our
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interaction studies identified subunits of V-ATPases as promi-
nent candidate interactors of BBLN-1 and BBLN. Whether these
interactions are indeed involved in IF regulation or other aspects
of BBLN-1/BBLN function remains to be determined. A final
intriguing hypothesis is that BBLN-1 is involved in protein aggre-
gation. BBLNwas found in a search for highly heat-resistant pro-
teins that protect different subsets of proteins from aggregation
or denaturation under stress conditions.46 Indeed, BBLN is
differentially expressed in diseases characterized by protein ag-
gregation, including amyotrophic lateral sclerosis (ALS),47
Alzheimer’s,48 and Parkinson’s disease.49 As the loss of BBLN-
1 leads to IF aggregation, a potential future avenue of investiga-
tion is to examine whether BBLN-1 plays a direct role in protect-
ing against protein aggregation.
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8. Pásti, G., and Labouesse, M. (2014). Epithelial junctions, cytoskeleton,
and polarity. WormBook, 1–35.
9. Coch, R.A., and Leube, R.E. (2016). Intermediate filaments and polariza-
tion in the intestinal epithelium. Cells 5, 32.
10. Bossinger, O., Fukushige, T., Claeys, M., Borgonie, G., and McGhee, J.D.
(2004). The apical disposition of the Caenorhabditis elegans intestinal ter-
minal web is maintained by LET-413. Dev. Biol. 268, 448–456.
11. Munn, E.A., and Greenwood, C.A. (1984). The occurrence of submicrovil-
lar endotube (modified terminal web) and associated cytoskeletal struc-
tures in the intestinal epithelia of nematodes. Philos. Trans. R. Soc. B
Biol. Sci. 306, 1–18.
ll
OPEN ACCESS
2344 Current Biology 31, 2334–2346, June 7, 2021
Article
12. Coulombe, P.A., andWong, P. (2004). Cytoplasmic intermediate filaments
revealed as dynamic and multipurpose scaffolds. Nat. Cell Biol. 6,
699–706.
13. Etienne-Manneville, S. (2018). Cytoplasmic intermediate filaments in cell
biology. Annu. Rev. Cell Dev. Biol. 34, 1–28.
14. Geisler, F., and Leube, R.E. (2016). Epithelial intermediate filaments:
guardians against microbial infection? Cells 5, 29.
15. Salas, P.J., Forteza, R., and Mashukova, A. (2016). Multiple roles for ker-
atin intermediate filaments in the regulation of epithelial barrier function
and apico-basal polarity. Tissue Barriers 4, e1178368.
16. Sanghvi-Shah, R., and Weber, G.F. (2017). Intermediate filaments at the
junction of mechanotransduction, migration, and development. Front.
Cell Dev. Biol. 5, 81.
17. Toivola, D.M., Strnad, P., Habtezion, A., and Omary, M.B. (2010).
Intermediate filaments take the heat as stress proteins. Trends Cell Biol.
20, 79–91.
18. Carberry, K., Wiesenfahrt, T., Geisler, F., Stöcker, S., Gerhardus, H.,
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REAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
Rabbit anti-BBLN Sigma-Aldrich Cat# HPA020725; RRID: AB_1845816
Mouse anti-PCNT Abcam Cat# ab28144; RRID: AB_2160664
Rat anti-Tyrosinated a-tubulin (YL1/2) Thermo Fisher Scientific Cat# MA1-80017; RRID: AB_2210201
Rat anti-KRT8 DSHB Cat# TROMA-I; RRID: AB_531826
Alexa Fluor 568-conjugated Phalloidin Life Technologies Cat# A12380
Goat anti-mouse Alexa Fluor 488 Life Technologies Cat# A11029; RRID: AB_2534088
Goat anti-rabbit Alexa Fluor 594 Thermo Fisher Scientific Cat# A-11012; RRID AB_2534079
Goat anti-rat Alexa Fluor 647 Thermo Fisher Scientific Cat# A-21247; RRID AB_141778
Rabbit anti-GFP Abcam Cat# AB290; RRID: AB_2313768
Goat anti-rabbit IgG Antibody, IRDye 680LT Conjugated LI-COR Biosciences Cat# 827-11081; RRID: AB_10795015
Goat anti-rat IgG Antibody, IRDye 800CW Conjugated LI-COR Biosciences Cat# 926-32219; RRID: AB_1850025
Bacterial and virus strains
E. coli OP50 CGC N/A
E. coli DH5a Thermo Fisher Scientific Cat# 18265017
E. coli HT115 CGC N/A
Vidal full-length HT115 RNAi feeding library SourceBioScience 3320_Cel_ORF_RNAi
Ahringer fragment HT115 RNAi feeding library SourceBioScience 3318_Cel_RNAi_complete
Chemicals, peptides, and recombinant proteins
Vectashield mounting medium with DAPI Vector Laboratories Cat# H-1200
PEI PolySciences Cat# 24765–2
cOmplete, EDTA-free Protease Inhibitor Cocktail Roche Cat# 4693116001
Dextran, Texas Red, 3000 MW Thermo Fisher Scientific Cat# D3329
Dextran, Texas Red, 10,000 MW Thermo Fisher Scientific Cat# D1828
Dextran, Texas Red, 40,000 MW Thermo Fisher Scientific Cat# D1829
Alt-R S.p. Cas9 Nuclease V3 IDT Cat# 1081058
Auxin Alfa Aesar Cat# A10556
Critical commercial assays
MinElute PCR purification kit QIAGEN 28004
Dynabeads M-280 streptavidin beads Thermo Fisher Cat# 11206D
Deposited data
Mass Spectrometry data PRIDE PXD024387
Experimental models: cell lines
Human embryonic kidney 239T (HEK293T) ATCC Cat# CRL-3216
HeLa (Kyoto) Serra-Marques et al.50 N/A




wild type (Bristol) CGC N2
mibIs39[Prps-27::GFP-2xTEV-Avi 10 ng/ul + Prab-
3::mCherry 5 ng/ul + lambda DNA 65 ng/ul] I
This study BOX64
erm-1(mib15[erm-1::eGFP]) I Ramalho et al.30 BOX213
erm-1(mib15[erm-1::eGFP]) I; sma-5a(mib41[C370T]) X This study BOX320
(Continued on next page)
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Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
erm-1(mib15[erm-1::eGFP]) I; bbln-1(mib42[C13T]) X This study BOX321
bbln-1(mib71[eGFP::bbln-1]) X This study BOX414






























nrfl-1(mib72[nrfl-1::mCherry]) IV Boxem lab BOX416
ifb-2(mib74[ifb-2::mCherry]) II; bbln-1(mib70[Pbbln-






erm-1(mib40[erm-1::AID::mCherry])I; ifc-2a::yfp(kc16)X This study BOX456





















IV:5014740-5014802 (cxTi10882 site)]) IV; bbln-1(mib111
[eGFP::AID::bbln-1]) X
This study BOX632
erm-1(mib15)I; IFB-2(mib74[IFB-2::mCherry]) II; mibIs48
[Pelt-2::TIR-1::tagBFP2-Lox511::tbb-2-30UTR,
IV:5014740-5014802 (cxTi10882 site)]) IV; bbln-1(mib111
[GFP::AID::BBLN-1]) X
This study BOX637
erm-1(mib40[erm-1::AID::mCherry]) I; ifb-2(kc14) II; bbln-
1(mib70[Pbbln-1::eGFP1-3, X:3151104..3153328]) X
This study BJ364
(Continued on next page)
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Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Mike
Boxem (m.boxem@uu.nl).
Materials availability
Plasmids and C. elegans strains generated in this study are available upon request made to the Lead Contact.
Data and code availability
The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE partner
repository.52The accession number for the proteomics data is PRIDE: PXD024387.
Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
gip-2(lt19[gip-2::GFP]::loxP::cb-unc-119(+)::loxP)I; unc-
119(ed3)III
Wang et al.51 OD2509








See Table S1. N/A N/A
Recombinant DNA
Pvha-6::gfp::bbln-1::N-taglinker::tbb-2_30UTR This study pSMR10
vha-6 promoter This study pSMR13
tbb-2 30UTR This study pSMR18
Pvha-6::gfp::BBLN (Hs)::N-taglinker::tbb-2_30UTR This study pSMR30
act-5 30UTR (L4440) This study pSMR33
ifp-1 (L4440) This study pSMR34
ifd-1 (L4440) This study pSMR35
ifo-1 (L4440) This study pSMR36
L4440 Addgene Cat# 1654
pHSG298 Takara Biosciences Cat# 3298
pMLS257 Addgene Cat# 73716
pMLS288 Addgene Cat# 73735
pMLS287 Addgene Cat# 73730
pDD363 Addgene Cat# 91829
pDD398 Addgene Cat# 91832
Peft-3::Cas9 Addgene Cat# 46168
Pmyo-2::mCherry Addgene Cat# 19327
pJJR82 Addgene Cat# 75027
pJJR83 Addgene Cat# 75028
Software and algorithms
ImageJ Rasband,W.S (NIH) RRID: SCR_003070
Graphpad Prism GraphPad RRID: SCR_002798
Zen Black Zeiss RRID: SCR_018163
SnapGene Insightful Science RRID: SCR_015052
Proteome Discoverer 1.4 Thermo Scientific RRID: SCR_014477
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Caenorhabditis elegans strains and culture conditions
Caenorhabditis elegans strains were cultured on standard nematode growth medium (NGM) agar plates at 15 or 20C and fed with
Escherichia coli OP50.53 The Key resources table contains a list of all the strains used. Transgenic lines were generated by injecting
15 ng/ml of either plasmid pSMR10 or pSMR30 together with 65 ng/ml lambda DNA (Thermo Scientific) into the gonads of young
adults.
Cell line culture
HeLa and HEK293T cell lines were cultured in DMEM/Ham’s F10 (50:50) supplemented with 10% FCS and 1% penicillin/strepto-
mycin at 37 C and 5% CO2. All cell lines routinely tested negative for mycoplasma.
Organoid culture
Mouse small intestinal organoids derived from the duodenum of C57BL/6 mice were cultured in ENRmedium: Advanced DMEM/F12
(Invitrogen) with 1% Penicillin/Streptomycin (P/S, Lonza), 1% HEPES buffer (Invitrogen) and 1% Glutamax (Invitrogen), supple-
mented with 5% R-spondin conditioned medium, 10% Noggin conditioned medium, 50 ng/ml EGF (Invitrogen), 1x B27 (Invitrogen),
1.25 mM n-Acetyl Cysteine (Sigma-Aldrich).
METHOD DETAILS
Isolation and initial mapping of mib41 and mib42
L4 stage erm-1::GFP animals were incubated for 6 hours at room temperature (RT) in M9 buffer (0.22 M KH2PO4, 0.42 M Na2HPO4,
0.85 M NaCl, 0.001 MMgSO4) supplemented with 50 mM ethyl methanesulfonate (EMS), in a 15 mL tube with gentle rotation. Muta-
genized L4 animals were placed on 9 cm NGM agar plates seeded with E. coli (35 plates, 10 animals per plate) and allowed to lay
eggs. Parents were removed after 1000 F1 progeny had been produced. Three days after F1 progeny started egg-laying, all F1
adults and L2 larvae were washed off the plate, leaving behind a semi-synchronous population of F2 embryos. F2 animals were al-
lowed to develop for 2–4 days at 20C and scored for intestinal morphology defects using a Leica MZ16 fluorescence stereoscope.
Twomutants,mib41 andmib42, were isolated and backcrossed with N2males 3 times before further analysis. To identify an approx-
imate genetic location for bothmutations, single-nucleotide polymorphism (SNP) mapping using the polymorphic strain CB4856 was
performed as described previously.22
Genomic DNA purification
C. elegans lysis and genomic DNA purification were performed using the DNeasy Blood and Tissue kit (QIAGEN). Animals from two
recently starved populations were collected, pooled, washed twice using M9, and resuspended in 400 mL of lysis (ATL) buffer.
Samples were then flash-frozen in liquid nitrogen and stored overnight at80C. After three rounds of liquid nitrogen freeze-thawing,
proteinase Kwas added to a final concentration of 2mg/ml and samples were incubated for 3 hours at 56Cwhile shaking at 600 rpm.
Samples were further incubated with 2 mg/ml RNase A for 30 min at RT and for 10 min at 56C after addition of 400 mL of AL buffer.
Finally, samples were mixed with 400 mL of 100% ethanol and loaded into purification columns. Wash and elution steps were per-
formed according to the manufacturer’s instructions. Concentration of genomic DNA samples was measured using Qubit Fluoro-
metric Quantification (Invitrogen).
Identification of mib41 and mib42 mutations
Weused the sibling subtractionmethod to identify the causativemib41 andmib42mutations bywhole-genome sequencing (WGS).23
From heterozygous erm-1::GFP/+; mib41/+ or erm-1::GFP/+; mib42/+ hermaphrodites we isolated homozygous mib41 or mib42
mutant, homozygous nonmutant, or heterozygous F2 progeny. Genomic DNA was then purified from pooled F3 progeny derived
from 12–16 F2 animals and sequenced on an Illumina HiSeq X Ten platform.
To prepare the raw sequence data (provided in FASTQ format) for variant analysis, we first removed adapters and low
quality leading or trailing bases using Trimmomatic version 0.38:54 java -jar trimmomatic-0.35.jar PE input_forward.fq.gz
input_reverse.fq.gz output_forward_paired.fq.gz output_forward_unpaired.fq.gz output_reverse_paired.fq.gz output_reverse_
unpaired.fq.gz ILLUMINACLIP:TruSeq3-PE-2.fa:2:30:10 LEADING:3 TRAILING:3 SLIDINGWINDOW:4:15 MINLEN:36.
Next, reads were aligned to the C. elegans reference genome (UCSC genome release ce11) using the Burrows-Wheeler Aligner
version 0.7.17 BWA-MEM algorithm (http://bio-bwa.sourceforge.net): bwa mem -M ce11.fa read1.fq read2.fq > output.sam.
Third, non-aligned pairs were removed using the sam_bitwise_flag_filter.py script from the Galaxy project (https://galaxyproject.
org): python sam_bitwise_flag_filter.py -f input.sam–flag_column 2 ‘–0x0001 = 1’ ‘–0x0002 = 1’ > output.sam.
Fourth, Picard tools version 2.18.14 (http://broadinstitute.github.io/picard/) and Samtools version 1.9 (http://www.htslib.org/) were
used to convert the Sequence Alignment Map (SAM) file into a variant analysis-ready Binary Alignment Map (BAM). A sequence dictio-
nary file was created for the C. elegans reference genome (java -jar picard.jar CreateSequenceDictionary -O ce11.dict -R ce11.fa) and
added to the SAM file (cat ce11.dict aligned_reads.sam > output.sam). The SAM file was then sorted by coordinate (java -jar
picard.jar SortSam -I input.sam -O output.sam -SO coordinate), read group names were added and the file converted to BAM format
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(java -jar picard.jar AddOrReplaceReadGroups -I input.sam -O output.bam -RGID rgid -RGLB lib1 -RGPL illumina -RGPU unit1 -RGSM
sample_name -SORT_ORDER coordinate).
Finally, duplicate reads were marked (java -jar picard.jar MarkDuplicates -I input.bam -O output.bam -M metrics.txt -REMOVE_
DUPLICATES true -ASSUME_SORT_ORDER coordinate) and the BAM file was indexed (bamtools index -in input.bam).
Variant discovery was performed using the Genome Analysis Toolkit (GATK version 4.0.9.0) (https://gatk.broadinstitute.org/hc).
First, variants were called per-sample using HaplotypeCaller in genomic variant call format (gVCF) mode: gatk HaplotypeCaller -R
ce11.fa -I input.bam O output.g.vcf.gz -ERC GVCF. Next, per-sample gVCF files (mutant, heterozygous, and wild-type pools for
both mutants) were combined into a multi-sample gVCF file: gatk CombineGVCFs -R ce11.fasta -V input1.g.vcf.gz -V input2.g.vcf.gz
(etc) -O output.g.vcf.gz. Finally, joint genotyping was performed on the combined gVCF file: gatk GenotypeGVCFs -R ce11.fasta -V
input.g.vcf.gz -O output.vcf..
To identify candidate causativemutations, we first added genomic variant annotations and functional effect predictions to the VCF file
usingSnpEff (Version 4.3Twith annotation fileWBcel235.86):55 java -jar snpEff.jarWBcel235.86 input.vcf. > output.vcf.. The relevant data
was then exported to a tab-delimited table using GATK: gatk VariantsToTable -R ce11.fa -F CHROM -F POS -GF AD -F ANN -O
output.tab. This exports the chromosome, position, allelic depth (the number of reads corresponding to the reference and that are
variant), and the annotation.
Final analysis was done in Microsoft Excel, by selecting variants present at a frequency > 0.8 in the homozygous mutant
sample, < 0.8 in the heterozygous sample, and < 0.1 in the homozygous wild-type sample. For both mutant alleles, only a single
variant from the resulting selection was predicted to affect a protein coding sequence, which was selected for further analysis.
Protein structure and domain predictions
General protein domain searches were done using the SMART service at http://smart.embl-heidelberg.de/. Coiled-coils predictions
were done using DeepCoil at https://toolkit.tuebingen.mpg.de/#/tools/deepcoil. Disorder predictions were done using DisEMBL at
http://dis.embl.de/. Default settings were used. EMBOSS Water analysis was used to calculate similarity between BBLN-1 and
bublin.
Phylogenetic analysis
To identify proteins related to C15C7.5/BBLN-1, we performed a three-iteration HMMER search against the Reference Proteomes
dataset at https://www.ebi.ac.uk/Tools/hmmer/.
Molecular cloning
SapTrap assembly was done as described56 using existing SEC donor modules57 or new donor modules generated by cloning PCR
fragments or custom gBlocks (IDT) into Eco53kI-digested vector pHSG298 (Takara Biosciences). For the Pvha-6::GFP::bbln-1::tbb-2
30UTR and Pvha-6::GFP::bublin (Hs)::tbb-2 30UTR rescue constructs, Pvha-6 was amplified from genomic N2 DNA, GFP and the
tbb-2 30UTR were amplified from prior plasmids, and the bbln-1 and bublin sequences were synthesized as gBlocks (IDT). GFP
sequence is codon-optimized and contains 3 artificial introns. A list of all used oligonucleotides (IDT) and gBlocks (IDT) is included
in Table S1 and used plasmids are listed in the Key resources table. PCR fragments were generated using Q5 Hot Start High-Fidelity
DNA Polymerase (New England Biolabs). All DNA vectors used for genome editing were purified from DH5a E. coli using a QIAGEN
midiprep kit. Annotated DNA files of all plasmids used are included as Methods S1.
CRISPR/Cas9 genome engineering
Endogenous gene fusions were generated in anN2 background by homology-directed repair of CRISPR/Cas9-induced DNA double-
strand breaks (DSBs). Microinjection of young adult hermaphrodite germlines was done using an inverted microinjection setup (Ep-
pendorf FemtoJet 4xmounted on a Zeiss Axio Observer A.1 equipped with an Eppendorf Transferman 4r). In cases where the sgRNA
target site was not disrupted by sequence integration, silent mutations were incorporated to prevent repeated DNA cleavage. In all
cases correct integration was confirmed by Sanger sequencing (Macrogen). A list of all DNA- and RNA-based reagents is included as
Table S1.
erm-1::mCherry was generated using the SEC method, using a plasmid-based repair template. sgRNA expression plasmids were
generated by ligating annealed oligo pairs into BbsI-digested pJJR50 as previously described.58 The repair template was assembled
into pMLS257 using SapTrap with custom and SEC modules as follows (from 50 to 30): left homology arm, a C-terminal linker
(pMLS287), mCherry, SEC (pDD363), auxin-inducible degron (AID; pDD398), and right homology arm. Homology arms of
600 bp upstream and downstream of the DSB were amplified from N2 genomic DNA. The injection mix contained: 60 ng/ml
Peft-3::Cas9 (Addgene #46168), 15 ng/ml repair template, 100 ng/ml for each sgRNA, and 2.5 ng/ml Pmyo-2::mCherry (Addgene
#19327). Three injected animals were pooled and incubated for 3 days at 20C before adding 250 ng/ml of hygromycin per plate.
Rol animals lacking visible mCherry expression were selected after 4–5 days. To eliminate the selection cassette through Cre-Lox
recombination, L1 progeny of selected homozygous Rol animals were heat-shocked in a water bath at 34C for 1 hour. Correct exci-
sion was confirmed by selection of non-Rol animals and subsequent Sanger sequencing. Sequence files of the final gene fusions are
included in Methods S1.
The bbln-1(mib70), GFP::bbln-1, and ifb-2::mCherry alleles were generated using the plasmid-free nested-CRISPR approach.59
Injection mixes contained the following reagents (IDT): 250 ng/ml Alt-R S.p. Cas9 Nuclease V3 (IDT), 2 mM step 1 ssODN repair
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template, 400 ng/ml step 2 PCR repair template, 4.5-5 mM step 1 and step 2 crRNAs, 10 mM tracrRNA, as well as 1 mM dpy-10 crRNA
and ssODN repair for co-CRISPR selection.60 Reagents for dpy-10 co-CRISPR selection were omitted in ifb-2::mCherry injection
mixes, and for bbln-1(mib70) only step 1 editing events were selected. To select for integration events, injected animals were trans-
ferred to individual plates and allowed to recover at 20C overnight before incubation at 25C for 2–3 days. F1 animals were either
visually screened for presence of fluorescence using a Leica MZ16 fluorescence stereomicroscope, or singled from plates with high
numbers of Dpy and Rol animals followed by PCR screening.
All other strains were produced using a plasmid-free protocol incorporating melting of double stranded DNA (dsDNA) repair tem-
plates.61 Selection of positive editing events was done by visually screening for expression of fluorescent protein, or by PCR analysis
of single animals from plates with high numbers of Rol animals.
Light microscopy
Imaging ofC. eleganswas done bymounting embryos or larvae on a 5% agarose pad in a 10mM Tetramisole solution in M9 buffer to
induce paralysis. Spinning disk confocal imaging was performed using a Nikon Ti-U microscope equipped with a Yokogawa CSU-
X1-M1 confocal head and an Andor iXon DU-885 camera, using a 60x 1.4 NA objective. Time-lapse imaging for FRAP experiments
was performed on a Nikon Eclipse-Ti microscope equipped with a Yokogawa CSU-X1-A1 spinning disk and a Photometrics Evolve
512 EMCCD camera, using a 100x 1.4 NA objective. Targeted photobleaching was done using an ILas system (Roper Scientific
France/ PICT-IBiSA, Institut Curie). Point-scanning confocal microscopy was done on a Zeiss AiryScan LSM 880 setup using a
Plan-Apochromat 63x 1.2 NA objective. bublin antibody test was imaged on an upright fluorescence Nikon Eclipse Ni-U microscope
using a Plan Apo Lambda 100x N.A. 1.45 oil objective. Confocal imaging for keratin 8 and bublin in HeLa cells was performed with
Leica TCS SP8 STED 3X microscope using HC PL APO 100x/1.4 oil STED WHITE objective driven by LAS X controlling software.
Microscopy data was acquired usingMetaMorph Microscopy Automation & Image Analysis Software (Spinning Disk), and Zen Black
software (AiryScan). All stacks along the z axis were obtained at 0.25 mm intervals. For quantifications, the same laser power and
exposure times were used within experiments.
Texas Red-dextran assay
Mixed-stage populations were collected in egg buffer (118 mM NaCl, 48 mM KCl, 2 mMMgCl2, 2 mM CaCl2, 25 mM HEPES pH 7.3)
and washed three times. The worm pellet was concentrated and resuspended in a solution containing 1 mg/ml Texas Red-dextran.
The samples were incubated for 90 min while shaking at 300 rpm in the dark. The dye in solution was removed by washing the sam-
ples with egg buffer until the solution was clear, and animals were either imaged directly or transferred to standard culture plates for 1
hour prior to imaging. Animals were paralyzed in 10mMTetramisole, transferred to a 5%agarose pad on a glass slide, and imaged by
spinning disk confocal microscopy.
FRAP experiments and analysis
For FRAP assays, laser power was adjusted in each experiment to avoid complete photobleaching of the selected area. Photo-
bleaching was performed on a circular region with a diameter of 30 or 40 px (respectively 3.33 or 4.44 mm) at the cortex, and recovery
was followed at 5 s intervals for 15 minutes. Time-lapse movies were analyzed in ImageJ. The size of the area for FRAP analysis was
defined by the full width at half-maximum of an intensity plot across the bleached region in the first post-bleach frame. For each time-
lapse frame, the mean intensity value within the bleached region was determined, and the background, defined as themean intensity
of a non-bleached region outside the animal, was subtracted. The mean intensities within the bleached region were corrected for
acquisition photobleaching per frame using the background-subtracted mean intensity of a similar non-bleached region at the cor-
tex, which was normalized to the corresponding pre-bleach mean intensity. FRAP recovery was calculated as the change in cor-
rected intensity values within the bleached region. The first frame after bleach was defined as 0, and the mean intensity of the 10
frames before bleach as 1.
Curve fitting was done using GraphPad Prism 8, on averaged recovery data per sample using non-linear regression analysis (least-
squares regression). One and two-phase association were tested and, in all cases, data were best fitted with a two-phase curve.
Feeding RNAi
RNAi clones for bbln-1, ifb-2, ifc-2 and ifd-2were obtained from the genomewide Vidal full-length HT115 RNAi feeding library derived
from the ORFeome 3.1 collection.62 The RNAi clone for ifc-1 was obtained from the genome wide Ahringer fragment HT115 RNAi
feeding library,63 supplied through Source BioScience. All clones were verified using Sanger sequencing. RNAi clones for ifo-1,
ifd-1, ifp-1, let-413 and sma-5 were generated by subcloning the corresponding cDNA into a modified L4440 RNAi feeding vector,
containing a linker with AscI and NotI restriction sites. To specifically target act-5, and no other actin isoforms that share extensive
sequence homology, we followed a previously described strategy and designed an RNAi clone against the unique 30UTR.64 For all
custom RNAi clones, fragments were amplified from a cDNA library, digested with AscI/NotI, ligated into AscI/NotI-digested L4440,
and transformed into E. coliDH5a. Single colonies were isolated, plasmid DNAwas purified, and presence of an insert was confirmed
by Sanger sequencing. Correct clones were re-transformed into E. coli HT115, again confirmed by sequencing and stored at 80C
in 50% glycerol (1:1). All primer pairs are listed in Table S1.
For feeding RNAi experiments, bacterial cloneswere pre-cultured in 2mL Lysogeny Broth (LB) supplementedwith 100 mg/ml ampi-
cillin and 2.5 mg/ml tetracycline at 37Cwhile rotating at 200 rpm for 6–8 hours, and then transferred to new tubes with a total volume
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of 10 mL and cultured overnight. An HT115 bacterial clone expressing the L4440 vector lacking an insert was used as a control in
feeding experiments. To induce production of dsRNA, cultures were incubated for 90 min in the presence of 1 mM Isopropyl
b-D-1-thiogalactopyranoside (IPTG). Bacterial cultures were pelleted by centrifugation at 3220 g for 15 min and concentrated 5x.
NGM agar plates supplemented with 100 mg/ml ampicillin and 1 mM IPTG were seeded with 250 mL of bacterial suspension, and
kept at room temperature for 48 hour in the dark. L1 or L4 hermaphrodites were placed on the seeded RNAi plates and incubated
at 20C.65
Electron microscopy
Young adult animals were transferred into a 100 mmdeepmembrane carrier containing 20%bovine serum albumin inM9worm buffer
(22 mM KH2PO4, 42 mM Na2HPO4, 86 mM NaCl, 1 mM MgSO4) and then high-pressure frozen in a Leica EM Pact high-pressure
freezer. A minimum of five samples with 10-20 animals were frozen per experiment. Quick freeze substitution with agitation using
1% OsO4, 0.2% uranyl acetate in acetone followed by rapid epoxy resin embedding was performed as previously described.
66,67
Subsequently, 50 nm thick sections of the embedded samples were prepared using a Leica UC7. These were contrasted for
10 min in 1% uranyl acetate in ethanol and Reynolds lead citrate and recorded at 100 kV on a Hitachi H-7600 transmission electron
microscope (Tokyo, Japan).
Auxin Inducible Degradation
Auxin treatment was performed by transferring worms to NGM plates seeded with E. coli OP50 and containing 1 mM auxin. To pre-
pare plates, auxin was added to the autoclaved NGM agar medium after cooling to 60C prior to plate pouring. Plates were kept for a
maximumof 2 weeks in the dark at 4C. 40 adults were placed on NGMplates seededwith E. coliOP50 and allowed to lay eggs. After
1 hour of egg laying, plates were washed with M9 (0.22 M KH2 PO4, 0.42 M Na2 HPO4, 0.85 M NaCl, 0.001 M MgSO4) buffer to
remove larvae and adults. For the auxin withdrawal experiments, additional synchronization was performed by washing the plates
with M9 again after 1 h, to collect larvae hatched within that time span.
Affinity-purification and mass spectrometry analysis
GFP pull-down from C. elegans
Animals endogenously expressingGFP-tagged BBLN-1 or control animals expressing an integratedGFP transgene58 were grown on
6–8 9 cmNGMplates until starvation, to enrich for L1 animals. Animals were then transferred into 250mL of S-Medium supplemented
with 1% Penn/Strep (Life Technologies), 0.1% nystatin (Sigma) and OP50 bacteria obtained from the growth of a 400 mL culture.
Animals were grown at 20C at low shaking for 96 hours and were harvested and cleaned using a sucrose gradient, as previously
described58 with one exception being the inclusion of MgSO4 in the M9 medium. Worms were distributed into 15 mL TPX tubes
(Diagenode) to reach 200–400 ml worm pellet per tube and were washed with lysis buffer (25mM Tris-HCl pH 7.5, 150mM NaCl,
1mM EDTA, 0.5% IGEPAL CA-630, 1X cOmplete Protease Inhibitor Cocktail (Roche)). The liquid was removed, and the sample
was flash frozen in liquid nitrogen for storage at 80C.
To lyse the worms, tubes were thawed on ice and ice-cold lysis buffer was added to reach a total volume of 2 ml. Tubes were son-
icated for 10 mins (sonication cycle: 30 s ON, 30 s OFF) at 4C in a Bioruptor ultrasonication bath (Diagenode) at high energy setting.
After lysis, lysates were cleared by centrifugation and protein levels were measured using the Bradford BCA assay (Thermo
Scientific).
Immunoprecipitation was performed usingGFP-TrapMagnetic Agarose beads (Chromotek) according tomanufacturer’s protocol,
using 25 ml of beads per sample. To prep the beads, they were first equilibrated in wash buffer (10 mM Tris/Cl pH 7.5, 150 mM NaCl,
0.5 mM EDTA, 0.1% IGEPAL CA-630), blocked with 1% BSA for 1 hour, then washed 4 times with wash buffer. Next, lysate was
added to the beads and they were incubated for 1 hour tumbling end-over-end. Lysate was then removed, and the beads were
washed 4 times in wash buffer. After the final wash step, all liquid was removed, and the beads were flash frozen with liquid nitrogen.
The experiment was performed in triplicate (biological replicates) and processed on independent days.
Biotin-streptavidin pull-down from cells
Confluent HEK293T cells were split in a 1:3 dilution 24 hours before transfection. Cells were transfected with overexpression con-
structs indicated in figure legend together with BirA. 1 mg/mL PEI (Polyethylenimine HCl MAX Linear MW 40000 (PolySciences,
24765–2)) and 1 mg/mL DNA (3:1) weremixed in Ham’s F10 and incubated for 5 minutes at room temperature. Themixture was added
to cells and incubated for 24 hours to allow expression. The cells were harvested in ice-cold PBS and lysed with lysis buffer (150 mM
Tris-HCl pH 7.5, 150 mM NaCl, 1% Triton X-100 and cOmplete protease inhibitor cocktail (Roche)). 90% of each cell lysate was
centrifuged at 13,000 rpm for 5 minutes and the supernatants were transferred and incubated with streptavidin beads (Dynabeads
M-280, Invitrogen), which were already blocked by 0.2% Chicken Egg Albumine (Sigma). The remaining cell lysates were denatured
with SDS/DTT sample buffer and used as input sample. Beads were incubated for 40 minutes at 4C, before washing 5 times with
washing buffer (100mM Tris pH7.5, 150 mM NaCl, 0.5% Triton X-100 and 0.5x protease inhibitor cocktail).
Western blot analysis for bublin/keratin pull-down
For western blot assays, pull-down samples were eluted with SDS/DTT sample buffer and boiled for 5 min at 95C. Both pull-down
and input were loaded into 10% SDS-PAGE gels and transferred to nitrocellulose membrane. Membranes were blocked with 2%
BSA (bovine serum albumin) in PBS/0.05% Tween-20. Primary antibodies were diluted in blocking buffer and incubated with the
membranes overnight at 4C, washed 3 times with PBS/0.05% Tween-20 and incubated with IRDye 680LT and IRDye 800CW
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antibodies (LI-CORBiosciences) for 45min at RT.Membraneswerewashed 3 timeswith PBS/0.05%Tween-20 before imaging on an
Odyssey Infrared Imaging system (LI-COR Biosciences).
Mass spectrometry analysis for BBLN-1/bublin
Streptavidin and anti-GFP beads after affinity purification were resuspended in 15 mL of 43 Laemmli sample buffer (Biorad), boiled at
99C for 10 min and supernatants were loaded on 4%–12% Criterion XT Bis–Tris precast gel (Biorad). The gel was fixed with 40%
methanol and 10% acetic acid and then stained for 1 hour using colloidal Coomassie dye G-250 (Gel Code Blue Stain, Thermo Sci-
entific). Each lane from the gel was cut and placed in 1.5 mL tubes. Samples were then washed with 250 mL of water, followed by
15 min dehydration in acetonitrile. Proteins were reduced (10mM DTT, 1 hour at 56C), dehydrated and alkylated (55mM iodoace-
tamide, 1 hour in the dark). After two rounds of dehydration, trypsin was added to the samples and incubated overnight at 37C. Pep-
tides were extracted with acetonitrile, dried down and reconstituted in 10% formic acid prior to MS analysis.
Sampleswere analyzed on anOrbitrapQ-Exactivemass spectrometer (Thermo Fisher Scientific) coupled to an Agilent 1290 Infinity
LC (Agilent Technologies). Peptides were loaded onto a trap column (Reprosil pur C18, Dr. Maisch, 100 mm 3 2 cm, 3 mm; con-
structed in-house) with solvent A (0.1% formic acid in water) at a maximum pressure of 800 bar and chromatographically separated
over the analytical column (Poroshell 120 EC C18, Agilent Technologies, 100 mm x 50 cm, 2.7 mm) using 90 min linear gradient from
7% to 30% solvent B (0.1% formic acid in acetonitrile) at a flow rate of 150 nL min1. The mass spectrometers were used in a data-
dependent mode, which automatically switched between MS and MS/MS. After a survey scan from 375 to 1600 m/z the 10 most
abundant peptides were subjected to HCD fragmentation. MS spectra were acquired with a resolution > 30,000, whereas MS2
with a resolution > 17,500.
Raw data files were converted to mgf files using Proteome Discoverer 1.4 software (Thermo Fisher Scientific). Database search
was performed using the C. elegans or the human database and Mascot (version 2.5.1, Matrix Science, UK) as the search engine.
Carbamidomethylation of cysteines was set as a fixed modification and oxidation of methionine was set as a variable modification.
Trypsin was set as cleavage specificity, allowing a maximum of two missed cleavages. Data filtering was performed using a perco-
lator, resulting in 1% false discovery rate (FDR). Additional filters were search engine rank 1 and mascot ion score > 20.
Crapome68 was used to analyze BBLN-1 interacting proteins in three biological replicas and bublin binding proteins in a single
experiment, using proteins identified in the GFP pull downs as control. Significance analysis of interactome (SAINT) score69 and
simpler fold-change (FC) calculations FC-A and FC-B were derived from the Crapome analysis by averaging the spectral counts
across the controls. FC-A averages the counts across all controls while themore stringent FC-B takes the average of the top 3 highest
spectral counts for the abundance estimate.
Antibodies and Immunofluorescence Cell Staining
We used rabbit polyclonal antibodies against bublin (Sigma-Aldrich Cat# HPA020725, RRID: AB_1845816), mouse monoclonal an-
tibodies against PCNT (Abcam Cat# ab28144, RRID: AB_2160664), and rat monoclonal antibodies against tyrosinated a-tubulin
(YL1/2; Thermo Fisher Scientific Cat# MA1-80017, RRID: AB_2210201) and KRT8 (DSHB Cat# TROMA-I, RRID: AB_531826). We
used Alexa Fluor 568-conjugated Phalloidin to stain actin (Life Technologies). We used Alexa Fluor 488-, 594- and 647-conjugated
goat antibodies against respectively mouse, rabbit and rat (Life Technologies) as secondary antibodies.
HeLa cells were fixedwith20Cmethanol or 4%PFA for 10min and permeabilized with 0.1%Triton X-100 in phosphate-buffered
saline (PBS) for 10 min. Subsequent washing and labeling steps were carried out in PBS supplemented with 2% bovine serum albu-
min and 0.05% Tween-20. Slides were rinsed in 70 and 100% ethanol and mounted in Vectashield mounting medium supplemented
with DAPI (Vector Laboratories).
Mouse small intestinal organoids were fixed in suspension using ice-cold 4% PFA (Aurion) and immunolabeled as described
previously.70
QUANTIFICATION AND STATISTICAL ANALYSIS
Image analysis
Invagination numbers in bbln-1(null) animals were counted manually from intestinal rings int2 to int4, using Z stacks that span the
entire intestinal lumen. Invagination widths were measured by determining the full width at half-maximum of an intensity plot drawn
across the center of the invagination in an orthogonal view. Corresponding cell lengths were quantified by drawing a spline through
the lumen from lateral membrane to lateral membrane. Intensity distribution profiles of fluorescent proteins at the apical domains of
the intestine or organoids were obtained by performing a 40-pixel (4.7 mm) wide line-scan perpendicular to the apical membrane.
GFP::BBLN-1 intensity at the apical domain was determined by taking the maximum intensity value of a 40-pixel wide line-scan
perpendicular to the apical membrane, and subtracting the mean background intensity (measured in a 40-pixel diameter circle
outside of the worm). Each data point shown represents the average of 6–8 measurements per animal. All images were analyzed
and processed using ImageJ alone (spinning disk) or in combination with Zen Black software (Airyscan).
Quantification of brood size and lethality
Starting at the L4 stage, individual P0 animals were cultured at 20C and transferred to a fresh plate every 24 hours for 6 days.
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Statistical analysis
All statistical analyses were performed using GraphPad Prism 8. For population comparisons, a D’Agostino & Pearson test of
normality was first performed to determine if the data was sampled from a Gaussian distribution. For data drawn from a Gaussian
distribution, comparisons between two populations were done using an unpaired t test, with Welch’s correction if the SDs of the-
populations differ significantly, and comparisons between > 2 populations were done using a one-way ANOVA if the SDs of the pop-
ulations differ significantly. For data not drawn from a Gaussian distribution, a non-parametric test was used (Mann-Whitney for 2
populations and Kruskal-Wallis for > 2 populations). ANOVA and non-parametric tests were followed up with multiple comparison
tests of significance (Dunnett’s, Tukey’s, Dunnett’s T3 or Dunn’s). Tests of significance used and sample sizes are indicated in
the figure legends. No statistical method was used to pre-determine sample sizes. No samples or animals were excluded from anal-
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